High blood pressure trials in Bulgaria
6 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Where
- Byala, Dupnitsa, Gabrovo, Gotse Delchev, Pernik, Plovdiv, Ruse, Sandanski, Sevlievo, Sliven, Sofia, Sofiya, Varna, Veliko Tirnovo
- Age
- 18 years and over
- People
- 5,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00 - Phase 3Not yet taking people in BulgariaA Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity
- Where
- Burgas, Panagyurishte, Pernik, Plovdiv, Shumen, Sliven, Sofia, Varna
- Age
- 18 years and over
- People
- 1,408 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07919405 - Phase 3Taking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Dimitrovgrad, Dupnitsa, Gabrovo, Kyustendil, Pernik, Pleven, Plovdiv, Sofia, Sofiya, Stara Zagora, Yambol
- Age
- 18 years and over
- People
- 11,800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - Phase 3Taking peopleZilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Where
- Blagoevgrad, Botevgrad, Burgas, Dimitrovgrad, Gabrovo, Haskovo, Montana, Pleven, Plovdiv, Rousse, Sliven, Smolyan, Sofia, Stara Zagora, Varna, Veliko Tarnovo
- Age
- 18 years and over
- People
- 11,000 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT07181109 · EU 2025-522960-34-00 - Phase 3Enrolling by invitationA Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
- Where
- Sofia, Sofiya
- Age
- 18 years and over
- People
- 1,000 worldwide
- Run by
- United Therapeutics
See details and how to joinNCT03683186 · EU 2023-509305-68-00 - No phaseTaking peopleIntegrated Approach in Frail Older People with Atrial Fibrillation
- Where
- Haskovo, Pernik, Plovdiv, Sofia
- Age
- 65 years and over
- People
- 1,250 worldwide
- Run by
- Heart Care Foundation
See details and how to joinNCT06775028